This proposed 2-stage randomized controlled trial (RCT) will evaluate a personalized patient-centered adherence intervention iTAB-CV + Self-Monitoring (iTAB-CV + SM) vs. Self-Monitoring (SM) alone in poorly adherent hypertensive persons with BD or MDD. This practical, technology-facilitated intervention has potential to improve adherence to antihypertensive medication and reduce SBP among high-risk individuals. The intervention is suitable for primary care or mental health settings and has potential for broad scale-up.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in the Tablet Routine Questionnaire (TRQ)
Timeframe: Baseline and Month 4
Change in systolic blood pressure (SBP)
Timeframe: Baseline and Month 4
Change in Adherence based on the Electronic Monitoring Device (eCAP)
Timeframe: Baseline and Month 4